NEW YORK, Feb. 20, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Tissue Engineering: The Combination of Cells & Engineering – A Global Market Overview
http://www.reportlinker.com/p0774604/Tissue-Engineering-The-Combination-of-Cells–Engineering—A-Global-Market-Overview.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy
Advancements of novel therapies in the fields of tissue engineering and regenerative medicine have opened up new avenues for addressing a range of major diseases such as cancer; skin; cardiovascular conditions; urology; dental; neurological disorders including Alzheimer’s and Parkinson’s; and other. Engineered tissues can be successfully constructed through the recreation of a biologically active extracellular environment in which the product can be developed. These technologies offer new hope for medical progress, and the economies of emerging nations have recognized the potential of tapping into these fast emerging fields to gain maximum mileage.
The global market for the therapeutic areas of Tissue Engineering analyzed in this study comprises Orthopedics, Integumentary, Oncology, Cardiology, Dental, Neurology and Other. Individual regions analyzed in the study includes the United States, Europe, Asia-Pacific and Rest of World. Estimated to value US$11 billion in 2012, the global market for tissue engineering is expected to touch US$27 billion by 2018.
Read More: Tissue Engineering: The Combination of Cells & Engineering – A Global Market Overview
Cartoon by Bob Moran
